N
Norbert Schülke
Researcher at Millennium Pharmaceuticals
Publications - 6
Citations - 797
Norbert Schülke is an academic researcher from Millennium Pharmaceuticals. The author has contributed to research in topics: Gp41 & Epitope. The author has an hindex of 6, co-authored 6 publications receiving 785 citations.
Papers
More filters
Journal ArticleDOI
Fine Definition of the Epitope on the gp41 Glycoprotein of Human Immunodeficiency Virus Type 1 for the Neutralizing Monoclonal Antibody 2F5
Carol E. Parker,Leesa J. Deterding,Christine Hager-Braun,James M. Binley,Norbert Schülke,Hermann Katinger,John P. Moore,Kenneth B. Tomer +7 more
TL;DR: In this article, a matrix assisted laser desorption ionization mass spectrometry (MALDI-MS) was used to identify the functional epitope on human immunodeficiency virus envelope glycoprotein gp41 for the broadly neutralizing anti-gp41 human monoclonal antibody 2F5.
Journal ArticleDOI
Oligomeric and Conformational Properties of a Proteolytically Mature, Disulfide-Stabilized Human Immunodeficiency Virus Type 1 gp140 Envelope Glycoprotein
Norbert Schülke,Mika Vesanen,Rogier W. Sanders,Ping Zhu,Min Lu,Deborah J. Anselma,Anthony R. Villa,Paul W. H. I. Parren,James M. Binley,Kenneth H. Roux,Paul J. Maddon,John P. Moore,William C. Olson +12 more
TL;DR: The application of Blue Native polyacrylamide gel electrophoresis (BN-PAGE), a high-resolution molecular sizing method, to the study of viral envelope proteins has relevance for rational vaccine design.
Journal ArticleDOI
Redox-Triggered Infection by Disulfide-Shackled Human Immunodeficiency Virus Type 1 Pseudovirions
James M. Binley,Charmagne Cayanan,Cheryl Wiley,Norbert Schülke,William C. Olson,Dennis R. Burton +5 more
TL;DR: This disulfide-shackled virus is a unique tool with potential utility in vaccine design, drug discovery, and elucidation of the HIV-1 entry process, suggesting that downstream fusion events and structures figure prominently in the host immune response.
Journal ArticleDOI
A comparative immunogenicity study of HIV-1 virus-like particles bearing various forms of envelope proteins, particles bearing no envelope and soluble monomeric gp120.
Emma T. Crooks,Penny L. Moore,Michael Franti,Charmagne Cayanan,Ping Zhu,Pengfei Jiang,Robbert P. de Vries,Robbert P. de Vries,Cheryl Wiley,Irina Zharkikh,Norbert Schülke,Kenneth H. Roux,David C. Montefiori,Dennis R. Burton,James M. Binley +14 more
TL;DR: The data suggests that Env-VLP sera were primarily focused on nonfunctional forms of Env on VLP surfaces, possibly gp120/gp41 monomers and not the trimers, which suggests that to make progress toward a more effective VLP-based vaccine, it will need to find ways to refocus the attention of B cells on native trimers.
Journal ArticleDOI
Evaluating the Immunogenicity of a Disulfide-Stabilized, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1
Simon Beddows,Norbert Schülke,Marc W. Kirschner,Kelly Barnes,Michael Franti,Elizabeth Michael,Thomas J. Ketas,Rogier W. Sanders,Paul J. Maddon,William C. Olson,John P. Moore +10 more
TL;DR: In this article, the authors report on the antibody responses generated in rabbits against a soluble, cleaved, trimeric form of HIV-1 JR-FL Env. Neutralization of these viruses was immunoglobulin mediated and was predominantly caused by antibodies to gp120 epitopes.